Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2017 October;152(5) > Giornale Italiano di Dermatologia e Venereologia 2017 October;152(5):441-6

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW   

Giornale Italiano di Dermatologia e Venereologia 2017 October;152(5):441-6

DOI: 10.23736/S0392-0488.17.05682-6

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Biomarkers for psoriasis skin lesions

Angelo M. D’ ERME 1, 2 , Francesca PAPADIA 1, Joerg WENZEL 3, Thomas BIEBER 3, Marco ROMANELLI 1, Andrea CHIRICOZZI 1

1 Unit of Dermatology, Livorno Hospital, Livorno, Italy; 2 Unit of Dermatology, University of Pisa, Pisa, Italy; 3 Department of Dermatology, University of Bonn, Bonn, Germany


PDF


Psoriasis is a common, chronic skin disease, whose diagnosis is based mainly on clinical features but, in some cases, can be difficult. As the exact diagnosis of psoriasis and the differential diagnosis with other diseases are crucial for the therapeutic choice, several studies investigated the relevance of some genes and proteins as potential specific skin biomarkers. Despite a large number of reports, none of them has been tested in large studies and thus achieved regulatory approval and clinical application. Authors give an overview on the skin biomarkers (BMs) in psoriasis, distinguishing inflammatory and epidermal biomarkers, highlighting the most distinctive skin psoriasis BMs, that can help physicians and pathologists to recognize psoriasis among “psoriasiform dermatitis”.


KEY WORDS: Biomarkers - Psoriasis - Skin

top of page